시장보고서

상품코드

1605912

비침습적 출생전 검사 시장 규모, 점유율, 동향, 산업 분석 리포트 : 임신 기간별, 컴포넌트별, 방법별, 용도별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

Non-Invasive Prenatal Testing Market Size, Share, Trends, Industry Analysis Report: By Gestation Period, Component, Method, Application, End Use, and Region - Market Forecast, 2025-2034

발행일: 2024년 11월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 120 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 비침습적 출생전 검사(NIPT) 시장 규모는 2034년까지 113억 9,000만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트를 제공하고, 향후 시장 성장에 관한 분석을 제공하고 있습니다.

비침습적 산전 검사(NIPT)는 임신한 개인의 혈액 샘플을 사용하여 다운증후군과 같은 태아의 특정 유전 질환을 선별하는 데 사용되는 방법을 말합니다. 이 검사는 산모의 혈액을 순환하는 태아의 작은 DNA 조각을 분석합니다. 침습적인 방법에 비해 정확하고 안전하므로 이용자들 사이에서 선호되고 있습니다.

유전성 질환의 조기 발견의 중요성이 높아지는 것이 NIPT 시장의 주요 촉진요인입니다. 유전체 기술과 바이오인포매틱스의 눈부신 발전이 NIPT 시장을 촉진하고 있습니다. 차세대 염기서열 분석(NGS) 기술의 발전으로 태아 DNA 분석의 정확성과 효율성이 향상되었습니다. 이러한 기술 혁신은 NIPT를 보다 저렴하고 쉽게 이용할 수 있는 옵션을 제공함으로써 의료 프로바이더와 환자들 사이에서 NIPT의 채택을 확대하고 있습니다. 예를 들어 2021년 5월 Illumina, Inc.와 Next Generation Genomic Co, Ltd.는 CE-IVD, NGS 기반 NIPT 접근 방식인 VeriSeq NIPT Solution v2의 출시를 발표했습니다. 기술이 계속 발전함에 따라 NIPT의 기능과 가격은 더욱 향상될 것으로 예상됩니다.

비침습적 산전 검사 시장은 가격 경쟁과 전략적 파트너십을 통한 기술 혁신 등의 전략으로 치열한 경쟁을 벌이고 있습니다. 예를 들어 2021년 7월 Pacific Biosciences of California, Inc.는 Omniome의 인수를 발표했습니다. 이번 인수를 통해 Pacific Biosciences는 고객에게 혜택을 줄 수 있는 창의적인 방식으로 시퀀서 시장 기회를 확대할 수 있게 되었으며, Omniome은 혁신적인 방법으로 고정밀 단쇄 염기서열 분석 플랫폼을 제공하여 비침습적 산전 검사, 종양학 등 빠르게 성장하는 임상 용도에 진출할 수 있게 되었습니다. 비침습적 산전검사, 종양학 등 빠르게 확대되고 있는 임상 용도로의 진입을 목표로 하고 있습니다.

또한 2024년 10월, Yourgene Health는 콜롬비아 최초의 비침습적 산전검사(NIPT) 워크플로우를 Genetix에 설치했습니다. 이 서비스는 콜롬비아의 임산부에게 빠르고 정확한 NIPT 결과를 제공하여 납기 및 배송 문제를 줄일 수 있습니다.

비침습적 산전 검사(NIPT) 시장 보고서 하이라이트

방법별 분석에서 모체 혈장 무세포 DNA 검사 부문이 2024년 시장을 장악할 것으로 예상되며, 이는 주로 기존 침습적 방법에 비해 위험이 적고 정확도가 높기 때문입니다.

용도별로는 21번 삼염색체증(다운증후군), 18번 삼염색체증(에드워즈 증후군), 13번 삼염색체증(파타우 증후군)과 같은 일반적인 염색체 이상 검출에 있으며, NIPT의 역할로 인해 2024년 삼염색체증 부문이 시장을 주도했습니다.

북미는 첨단 의료 인프라, 높은 인지도, 첨단 기술의 견고한 도입으로 2024년 시장을 장악했습니다.

아시아태평양은 경제 성장, 기술 혁신, 지역적 확장, 전략적 파트너십으로 인해 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.

주요 시장 기업 : Agilent Technologies, Inc., Centogene N.V., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche Ltd.(Ariosa Diagnostics), Agilent Technologies, Inc.(Ariosa Diagnostics), Illumina, Inc., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Women's Health, Inc., Natera, Inc., Progenity, Inc., Qiagen, Quest Diagnostics, Inc., Thermo Fisher Scientific, Inc.

용도 스냅숏
비침습적 출생전 검사(NIPT) 시장 역학
- 촉진요인과 기회
  - 시퀀싱 기술과 바이오인포매틱스에서 기술 진보의 증가
  - 출산 연령의 상승
- 억제요인과 과제
  - 비의학적 배경에 기반한 성별 선택을 위한 NIPT 적용은 일부 국가에서는 금지되어 있다.
PESTEL 분석
비침습적 출생전 검사(NIPT) 시장의 용도 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 비침습적 출생전 검사(NIPT) 시장 : 임신 기간별

주요 조사 결과
서론
0-12주
13-24주
25-36주

제6장 세계의 비침습적 출생전 검사(NIPT) 시장 : 컴포넌트별

주요 조사 결과
서론
소모품
기기
소프트웨어
서비스

제7장 세계의 비침습적 출생전 검사(NIPT) 시장 : 방법별

주요 조사 결과
서론
모체혈장 검사에서의 Cell-Free DNA
초음파 탐지
생화학 스크리닝 검사
기타

제8장 세계의 비침습적 출생전 검사(NIPT) 시장 : 용도별

주요 조사 결과
서론
모노소미
트리소미
미세결손 증후군
기타

제9장 세계의 비침습적 출생전 검사(NIPT) 시장 : 최종 용도별

주요 조사 결과
서론
진단 센터
병원과 진료소

제10장 세계의 비침습적 출생전 검사(NIPT) 시장 : 지역별

주요 조사 결과
서론
- 비침습적 출생전 검사(NIPT) 시장 평가 : 지역, 2020-2034년
북미
- 북미 : 임신 기간별, 2020-2034년
- 북미 : 컴포넌트별, 2020-2034년
- 북미 : 방법별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 임신 기간별, 2020-2034년
- 유럽 : 컴포넌트별, 2020-2034년
- 유럽 : 방법별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 임신 기간별, 2020-2034년
- 아시아태평양 : 컴포넌트별, 2020-2034년
- 아시아태평양 : 방법별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 임신 기간별, 2020-2034년
- 중동 및 아프리카 : 컴포넌트별, 2020-2034년
- 중동 및 아프리카 : 방법별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 임신 기간별, 2020-2034년
- 라틴아메리카 : 컴포넌트별, 2020-2034년
- 라틴아메리카 : 방법별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제11장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제12장 기업 개요

Agilent Technologies, Inc.
Centogene N.V
Eurofins LifeCodexx GmbH
F;Hoffmann-La Roche Ltd
Illumina, Inc
Laboratory Corp. of America Holdings
MedGenome Labs Ltd
Myriad Women's Health, Inc.
Natera, Inc.
Progenity, Inc.
Qiagen
Quest Diagnostics, Inc.
Thermo Fisher Scientific, Inc.

KSA 25.01.06

The non-invasive prenatal testing market size is expected to reach USD 11.39 billion by 2034, according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Trends, Industry Analysis Report: By Gestation Period (0-12 Weeks, 13-24 Weeks, and 25-36 Weeks), Component, Method, Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-invasive prenatal testing (NIPT) refers to a method used to screen for certain genetic conditions in a fetus, such as Down syndrome, using a blood sample from the pregnant individual. This test analyzes small fragments of fetal DNA that are circulating in the maternal blood. It is a preferred option among users for its accuracy and safety compared to invasive methods.

The growing importance of early detection of genetic disorders is a primary driver for the NIPT market. Significant advancements in genomic technology and bioinformatics have propelled the NIPT market. Improvements in next-generation sequencing (NGS) technology have enhanced the accuracy and efficiency of fetal DNA analysis. These technological innovations have led to more affordable and accessible NIPT options, thereby expanding its adoption among healthcare providers and patients. For instance, in May 2021, Illumina, Inc. and Next Generation Genomic Co., Ltd. announced the launch of VeriSeq NIPT Solution v2, a CE-IVD, NGS-based approach to NIPT. As technology continues to evolve, it is expected to improve the capabilities and affordability of NIPT further.

The non-invasive prenatal testing market is driven by intense competition with strategies including price competitiveness and technological innovation with strategic partnerships. For instance, in July 2021, Pacific Biosciences of California, Inc. announced the acquisition of Omniome. With the acquisition, Pacific Biosciences will be able to expand the market opportunity for sequencing in creative ways that benefit customers. Through its innovative methodology, Omniome aims to provide an accurate short-read sequencing platform to enable it to enter rapidly expanding clinical application areas such as non-invasive prenatal testing and oncology.

Additionaly, in October 2024, Yourgene Health installed the first non-invasive prenatal testing (NIPT) workflow in Colombia at Genetix. The service will deliver fast, precise NIPT results for expectant parents in Colombia, serving to reduce turnaround times and delivery problems.

Non-Invasive Prenatal Testing (NIPT) Market Report Highlights

By method analysis, the cell-free DNA in maternal plasma tests segment dominated the market in 2024, mainly attributed to its minimal risk and superior accuracy compared to traditional invasive methods.

By application analysis, the trisomy segment dominated the market in 2024 owing to NIPT's role in detecting common chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome).

North America dominated the market in 2024 due to advanced healthcare infrastructure, high awareness levels, and robust adoption of advanced technologies.

Asia Pacific is expected to register the fastest CAGR, owing to economic growth, technological innovation, geographic expansion, and strategic partnerships.

The key market players include Agilent Technologies, Inc.; Centogene N.V.; Eurofins LifeCodexx GmbH; F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics); Illumina, Inc.; Laboratory Corp. of America Holdings; MedGenome Labs Ltd.; Myriad Women's Health, Inc.; Natera, Inc.; Progenity, Inc.; Qiagen; Quest Diagnostics, Inc.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing market report based on gestation period, component, method, application, end use, and region:

By Gestation Period Outlook (Revenue - USD Billion, 2020-2034)

0-12 weeks
13-24 weeks
25-36 weeks

By Component Outlook (Revenue - USD Billion, 2020-2034)

Consumables
Instruments
Software
Services

By Method Outlook (Revenue - USD Billion, 2020-2034)

Cell-Free DNA in Maternal Plasma Tests
Ultrasound Detection
Biochemical Screening Tests
Others

By Application Outlook (Revenue - USD Billion, 2020-2034)

Monosomy
Trisomy
Microdeletion Syndrome
Others

By End-Use Outlook (Revenue - USD Billion, 2020-2034)

Diagnostic Centers
Hospitals and Clinics
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Malaysia
Vietnam
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Non-Invasive Prenatal Testing (NIPT) Market Insights

4.1. Non-Invasive Prenatal Testing (NIPT) Market - Application Snapshot
4.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising technological advancements in sequencing technologies and bioinformatics
  - 4.2.1.2. Rise in Maternal Age
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Application of NIPT for sex selection on non-medical backgrounds is prohibited in some countries.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Non-Invasive Prenatal Testing (NIPT) Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
5.3. 0-12 weeks
- 5.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2020-2034 (USD Billion)
5.4. 13-24 weeks
- 5.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2020-2034 (USD Billion)
5.5. 25-36 weeks
- 5.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2020-2034 (USD Billion)

6. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
6.3. Consumables
- 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, by Region, 2020-2034 (USD Billion)
6.4. Instruments
- 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2020-2034 (USD Billion)
6.5. Software
- 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2020-2034 (USD Billion)
6.6. Services
- 6.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2020-2034 (USD Billion)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
7.3. Cell-Free DNA in Maternal Plasma Tests
- 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2020-2034 (USD Billion)
7.4. Ultrasound Detection
- 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2020-2034 (USD Billion)
7.5. Biochemical Screening Tests
- 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
8.3. Monosomy
- 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, by Region, 2020-2034 (USD Billion)
8.4. Trisomy
- 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2020-2034 (USD Billion)
8.5. Microdeletion Syndrome
- 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2020-2034 (USD Billion)
8.6. Other
- 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
9.3. Diagnostic Centers
- 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
9.4. Hospitals and Clinics
- 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
- 10.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.3.7. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
  - 10.3.7.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.3.7.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.3.7.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.3.7.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.3.7.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.3.8. Non-Invasive Prenatal Testing (NIPT) Market - Canada
  - 10.3.8.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.3.8.2. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.3.8.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.3.8.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.3.8.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
- 10.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
  - 10.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
  - 10.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
  - 10.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
  - 10.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
  - 10.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.11. Non-Invasive Prenatal Testing (NIPT) Market - Netherlands
  - 10.4.11.1. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.12. Non-Invasive Prenatal Testing (NIPT) Market - Russia
  - 10.4.12.1. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.4.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia Pacific
- 10.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
  - 10.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
  - 10.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.8. Non-Invasive Prenatal Testing (NIPT) Market - Malaysia
  - 10.5.8.1. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
  - 10.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.10. Non-Invasive Prenatal Testing (NIPT) Market - Indonesia
  - 10.5.10.1. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.11. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
  - 10.5.11.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.12. Non-Invasive Prenatal Testing (NIPT) Market - Australia
  - 10.5.12.1. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.5.13. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
  - 10.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
  - 10.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
  - 10.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.6.10. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
10.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
- 10.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
  - 10.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
  - 10.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Argentina
  - 10.7.8.1. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)
- 10.7.9. Non-Invasive Prenatal Testing (NIPT) Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Gestation Period, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Component, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Method, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by Application, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Non-Invasive Prenatal Testing (NIPT) Market, by End Use, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Agilent Technologies, Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Centogene N.V
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Eurofins LifeCodexx GmbH
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. F; Hoffmann-La Roche Ltd
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Illumina, Inc
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Laboratory Corp. of America Holdings
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. MedGenome Labs Ltd
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Myriad Women's Health, Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Natera, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Progenity, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Qiagen
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Quest Diagnostics, Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
12.13. Thermo Fisher Scientific, Inc.
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development